Comparison between cold plasma, electrochemotherapy and combined therapy in a melanoma mouse model

Experimental Dermatology

Volumn 22, Issue 9, 2013, Pages 582-586

  Daeschlein, Georg ^a   Scholz, Sebastian ^a   Lutze, Stine ^a   Arnold, Andreas ^a   von Podewils, Sebastian ^a   Kiefer, Thomas ^a   Tueting, Thomas ^b   Hardt, Olaf ^c   Haase, Hermann ^a   Grisk, Olaf ^a   Langner, Sönke ^a   Ritter, Christoph ^a   von Woedtke, Thomas ^d   Jünger, Michael ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c MILTENYI BIOTEC GMBH   (Germany)

^d LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

Author keywords

Cold plasma; Cutaneous melanoma; Electrochemotherapy; Mouse model; Plasma medicine

Indexed keywords

BLEOMYCIN; FRESH FROZEN PLASMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCHEMOTHERAPY; FEMALE; MELANOMA; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84882255238     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12201     Document Type: Article

References (28)

1. Balch C M, Morton D L, Gershenwald J E et al. J Am Acad Dermatol 2009; 60: 872-875.
2. Ries L A G, Melbert D, Krapcho M et al. SEER cancer statistics review, 1945-2005. Bethesda, MD: National Cancer Institute, 2010; Accessed January 24.
3. Linos E, Swetter S M, Cockburn M G et al. J Invest Dermatol 2009; 129: 1666-1674.
4. RKI. Cancer in Germany 2005/2006 Incidence and Trends, Published jointly by the Robert Koch Institute and the Association of Population-based Cancer Registries in Germany, Seventh edition 2010.
5. Orlowski S, Belehradek J Jr, Paoletti C et al. Biochem Pharmacol 1988; 37: 4727-4733.
6. Mir L M. Bioelectrochemistry 2001; 53: 1-10.
7. Sersa G. EJC Suppl 2006; 4: 52-59.
8. Kis E, Oláh J, Ócsai H et al. Dermatol Surg 2011; 37: 816-824.
9. Fridman G, Shereshevsky A, Jost M et al. Plasma Chem Plasma Process 2007; 27: 163-176.
10. Vandamme M, Robert E, Pesnel S et al. Plasma Process Polym 2010; 7: 264-273.
11. Keidar M, Walk R, Shashurin A et al. Br J Cancer 2011; 105: 1295-1301.
12. Vandamme M, Robert E, Lerondel S et al. Int J Cancer 2012; 130: 2185-2194.
13. Weltmann K D, Kindel E, Brandenburg R et al. Contrib Plasma Phys 2009; 49: 631-640.
14. Brandenburg R, Ehlbeck J, Stieber M et al. Contrib Plasma Phys 2007; 47: 72-79.
15. Kuchenbecker M, Bibinov N, Kaemling A et al. J Phys D: Appl Phys 2009; 42: 045212.
16. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
17. Marty M, Sersa G, Garbay J R et al. EJC Suppl 2006; 4: 3-13.
18. Kim J Y, Kim S O, Wei Y et al. Appl Phys Lett 2010; 96: 203701.
19. Zirnheld J L, Zucker S N, DiSanto T M et al. IEEE Trans Plasma Sci 2010; 38: 948-952.
20. Georgescu N, Lupu A R. IEEE Trans Plasma Sci 2010; 38: 1949-1956.
21. Shashurin A, Keidar M, Bronnikov S et al. Appl Phys Lett 2008; 92: 181501.
22. Shashurin A, Stepp M A, Hawley T S et al. Plasma Process Polym 2010; 7: 294-300.
23. Kieft I E, Kurdi M, Stoffels E. IEEE Trans Plasma Sci 2006; 34: 1331-1336.
24. Fridman G, Friedman G, Gutsol A et al. Plasma Process Polym 2008; 5: 503-533.
25. Raiser J, Zenker M. J Phys D: Appl Phys 2006; 39: 3520-3523.
26. Snoj M, Cemazar M, Srnovrsnik T et al. Tumori 2009; 95: 398-402.
27. Babaeva N Y, Ning N, Graves D B et al. J Phys D: Appl Phys 2012; 45: 115203.
28. Connolly R J, Chapman T, Hoff A M et al. Hum Vaccin Immunother 2012; 8: 1729-1733.